Immunogenicity and safety of pneumococcal vaccination in patients with systemic sclerosis-Reference-Cited by-同舟云学术

Immunogenicity and safety of pneumococcal vaccination in patients with systemic sclerosis

Published:2018-01-08 Issue:4 Volume:57 Page:625-630
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Hesselstrand Roger¹,Nagel Johanna¹,Saxne Tore¹,Geborek Pierre¹,Skattum Lillemor²³,Kapetanovic Meliha C.¹

Affiliation:

1. Department of Clinical Sciences, Lund, Section for Rheumatology, Lund University and Skåne University Hospital, Lund, Sweden

2. Department of Laboratory Medicine, Section of Microbiology, Immunology and Glycobiology, Lund University, Lund, Sweden

3. Clinical Immunology and Transfusion Medicine University and Regional Laboratories, Region Skåne, Lund, Sweden

Funder

Swedish Rheumatism Association

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/57/4/625/24459398/kex471.pdf

Reference20 articles.

1. Toronto invasive bacterial diseases network. Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs;Shigayeva;Clin Infect Dis,2016

2. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases;van Assen;Ann Rheum Dis,2011

3. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP);Centers for Disease Control and Prevention (CDC);MMWR Morb Mortal Wkly Rep,2012

4. Systemic sclerosis;Denton;Lancet,2017

5. Mortality and causes of death in a Swedish series of systemic sclerosis patients;Hesselstrand;Ann Rheum Dis,1998

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert Panel Consensus Statements on Vaccination for Adults with AIRD in India;Indian Journal of Rheumatology;2024-09-04

2. Antibody status against measles and rubella in juvenile localized scleroderma patients on synthetic DMARDs: a prospective case–control study;Rheumatology;2024-03-18

3. Vaccinations in Patients with Systemic Sclerosis;Scleroderma;2024

4. Treatable Traits in Systemic Sclerosis;Clinical Reviews in Allergy & Immunology;2023-08-21

5. Recommendations for prevention of infection in systemic autoimmune rheumatic diseases;Reumatología Clínica (English Edition);2021-10